Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review.
第一作者:
T,Younis
第一单位:
Department of Medicine at Dalhousie University and the Atlantic Clinical Cancer Research Unit (ACCRU) at the Queen Elizabeth II Health Sciences Centre, 1276 South Park Street, Halifax, NS, B3H 2Y9, Canada. tallal.younis@nshealth.ca.
作者:
医学主题词
乳腺肿瘤(Breast Neoplasms);化学疗法, 辅助(Chemotherapy, Adjuvant);费用效益分析(Cost-Benefit Analysis);女(雌)性(Female);粒细胞集落刺激因子(Granulocyte Colony-Stimulating Factor);人类(Humans);中年人(Middle Aged);一级预防(Primary Prevention);质量校正寿命(Quality-Adjusted Life Years);二级预防(Secondary Prevention);存活率分析(Survival Analysis);治疗结果(Treatment Outcome)
DOI
10.1007/s10549-016-3954-1
PMID
27572552
发布时间
2025-06-26
- 浏览47
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



